Click for best price
Narcotic Opioid Drugs Market Size, Share 2023
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
This report aims to provide a comprehensive presentation of the global market for Narcotic (Opioid) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic (Opioid) Drugs. This report contains market size and forecasts of Narcotic (Opioid) Drugs in global, including the following market information:
Global Narcotic (Opioid) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Narcotic (Opioid) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Codeine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Narcotic (Opioid) Drugs include Pfizer, Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, Collegium, Johnson & Johnson, Merck and Mylan, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Narcotic (Opioid) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Narcotic (Opioid) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Narcotic (Opioid) Drugs Market Segment Percentages, by Type, 2022 (%)
- Codeine
- Fentanyl
- Hydrocodone
- Hydromorphone
- Meperidine
- Methadone
- Others
Global Narcotic (Opioid) Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Narcotic (Opioid) Drugs Market Segment Percentages, by Application, 2022 (%)
- Pain Relief Application
- Anesthesia Application
Global Narcotic (Opioid) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Narcotic (Opioid) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Narcotic (Opioid) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Narcotic (Opioid) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- Johnson & Johnson
- Merck
- Mylan
- Hikma Pharmaceuticals
- Sun Pharma
- Endo Pharmaceuticals
- Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Narcotic (Opioid) Drugs, market overview.
Chapter 2: Global Narcotic (Opioid) Drugs market size in revenue.
Chapter 3: Detailed analysis of Narcotic (Opioid) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Narcotic (Opioid) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Narcotic (Opioid) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Narcotic (Opioid) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Narcotic (Opioid) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Narcotic (Opioid) Drugs Overall Market Size
2.1 Global Narcotic (Opioid) Drugs Market Size: 2022 VS 2029
2.2 Global Narcotic (Opioid) Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Narcotic (Opioid) Drugs Players in Global Market
3.2 Top Global Narcotic (Opioid) Drugs Companies Ranked by Revenue
3.3 Global Narcotic (Opioid) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Narcotic (Opioid) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Narcotic (Opioid) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Narcotic (Opioid) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Narcotic (Opioid) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Narcotic (Opioid) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Narcotic (Opioid) Drugs Market Size Markets, 2022 & 2029
4.1.2 Codeine
4.1.3 Fentanyl
4.1.4 Hydrocodone
4.1.5 Hydromorphone
4.1.6 Meperidine
4.1.7 Methadone
4.1.8 Others
4.2 By Type - Global Narcotic (Opioid) Drugs Revenue & Forecasts
4.2.1 By Type - Global Narcotic (Opioid) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Narcotic (Opioid) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Narcotic (Opioid) Drugs Market Size, 2022 & 2029
5.1.2 Pain Relief Application
5.1.3 Anesthesia Application
5.2 By Application - Global Narcotic (Opioid) Drugs Revenue & Forecasts
5.2.1 By Application - Global Narcotic (Opioid) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Narcotic (Opioid) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Narcotic (Opioid) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Narcotic (Opioid) Drugs Revenue & Forecasts
6.2.1 By Region - Global Narcotic (Opioid) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Narcotic (Opioid) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Narcotic (Opioid) Drugs Revenue, 2018-2029
6.3.2 US Narcotic (Opioid) Drugs Market Size, 2018-2029
6.3.3 Canada Narcotic (Opioid) Drugs Market Size, 2018-2029
6.3.4 Mexico Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Narcotic (Opioid) Drugs Revenue, 2018-2029
6.4.2 Germany Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.3 France Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.4 U.K. Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.5 Italy Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.6 Russia Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Narcotic (Opioid) Drugs Market Size, 2018-2029
6.4.8 Benelux Narcotic (Opioid) Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Narcotic (Opioid) Drugs Revenue, 2018-2029
6.5.2 China Narcotic (Opioid) Drugs Market Size, 2018-2029
6.5.3 Japan Narcotic (Opioid) Drugs Market Size, 2018-2029
6.5.4 South Korea Narcotic (Opioid) Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Narcotic (Opioid) Drugs Market Size, 2018-2029
6.5.6 India Narcotic (Opioid) Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Narcotic (Opioid) Drugs Revenue, 2018-2029
6.6.2 Brazil Narcotic (Opioid) Drugs Market Size, 2018-2029
6.6.3 Argentina Narcotic (Opioid) Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Narcotic (Opioid) Drugs Revenue, 2018-2029
6.7.2 Turkey Narcotic (Opioid) Drugs Market Size, 2018-2029
6.7.3 Israel Narcotic (Opioid) Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Narcotic (Opioid) Drugs Market Size, 2018-2029
6.7.5 UAE Narcotic (Opioid) Drugs Market Size, 2018-2029
7 Narcotic (Opioid) Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Narcotic (Opioid) Drugs Major Product Offerings
7.1.4 Pfizer Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Teva
7.2.1 Teva Company Summary
7.2.2 Teva Business Overview
7.2.3 Teva Narcotic (Opioid) Drugs Major Product Offerings
7.2.4 Teva Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.2.5 Teva Key News & Latest Developments
7.3 Purdue Pharma
7.3.1 Purdue Pharma Company Summary
7.3.2 Purdue Pharma Business Overview
7.3.3 Purdue Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.3.4 Purdue Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.3.5 Purdue Pharma Key News & Latest Developments
7.4 Mallinckrodt
7.4.1 Mallinckrodt Company Summary
7.4.2 Mallinckrodt Business Overview
7.4.3 Mallinckrodt Narcotic (Opioid) Drugs Major Product Offerings
7.4.4 Mallinckrodt Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.4.5 Mallinckrodt Key News & Latest Developments
7.5 Amneal Pharma
7.5.1 Amneal Pharma Company Summary
7.5.2 Amneal Pharma Business Overview
7.5.3 Amneal Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.5.4 Amneal Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.5.5 Amneal Pharma Key News & Latest Developments
7.6 Collegium
7.6.1 Collegium Company Summary
7.6.2 Collegium Business Overview
7.6.3 Collegium Narcotic (Opioid) Drugs Major Product Offerings
7.6.4 Collegium Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.6.5 Collegium Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Major Product Offerings
7.7.4 Johnson & Johnson Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Narcotic (Opioid) Drugs Major Product Offerings
7.8.4 Merck Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Narcotic (Opioid) Drugs Major Product Offerings
7.9.4 Mylan Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Hikma Pharmaceuticals
7.10.1 Hikma Pharmaceuticals Company Summary
7.10.2 Hikma Pharmaceuticals Business Overview
7.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Major Product Offerings
7.10.4 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.10.5 Hikma Pharmaceuticals Key News & Latest Developments
7.11 Sun Pharma
7.11.1 Sun Pharma Company Summary
7.11.2 Sun Pharma Business Overview
7.11.3 Sun Pharma Narcotic (Opioid) Drugs Major Product Offerings
7.11.4 Sun Pharma Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.11.5 Sun Pharma Key News & Latest Developments
7.12 Endo Pharmaceuticals
7.12.1 Endo Pharmaceuticals Company Summary
7.12.2 Endo Pharmaceuticals Business Overview
7.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Major Product Offerings
7.12.4 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.12.5 Endo Pharmaceuticals Key News & Latest Developments
7.13 Allergan
7.13.1 Allergan Company Summary
7.13.2 Allergan Business Overview
7.13.3 Allergan Narcotic (Opioid) Drugs Major Product Offerings
7.13.4 Allergan Narcotic (Opioid) Drugs Revenue in Global Market (2018-2023)
7.13.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Narcotic (Opioid) Drugs Market Opportunities & Trends in Global Market
Table 2. Narcotic (Opioid) Drugs Market Drivers in Global Market
Table 3. Narcotic (Opioid) Drugs Market Restraints in Global Market
Table 4. Key Players of Narcotic (Opioid) Drugs in Global Market
Table 5. Top Narcotic (Opioid) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Narcotic (Opioid) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Narcotic (Opioid) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Narcotic (Opioid) Drugs Product Type
Table 9. List of Global Tier 1 Narcotic (Opioid) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Narcotic (Opioid) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Narcotic (Opioid) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Narcotic (Opioid) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Narcotic (Opioid) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Narcotic (Opioid) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Narcotic (Opioid) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Narcotic (Opioid) Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Narcotic (Opioid) Drugs Product Offerings
Table 32. Pfizer Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Teva Company Summary
Table 35. Teva Narcotic (Opioid) Drugs Product Offerings
Table 36. Teva Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Key News & Latest Developments
Table 38. Purdue Pharma Company Summary
Table 39. Purdue Pharma Narcotic (Opioid) Drugs Product Offerings
Table 40. Purdue Pharma Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Purdue Pharma Key News & Latest Developments
Table 42. Mallinckrodt Company Summary
Table 43. Mallinckrodt Narcotic (Opioid) Drugs Product Offerings
Table 44. Mallinckrodt Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Mallinckrodt Key News & Latest Developments
Table 46. Amneal Pharma Company Summary
Table 47. Amneal Pharma Narcotic (Opioid) Drugs Product Offerings
Table 48. Amneal Pharma Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Amneal Pharma Key News & Latest Developments
Table 50. Collegium Company Summary
Table 51. Collegium Narcotic (Opioid) Drugs Product Offerings
Table 52. Collegium Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Collegium Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Narcotic (Opioid) Drugs Product Offerings
Table 56. Johnson & Johnson Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Narcotic (Opioid) Drugs Product Offerings
Table 60. Merck Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Mylan Company Summary
Table 63. Mylan Narcotic (Opioid) Drugs Product Offerings
Table 64. Mylan Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Mylan Key News & Latest Developments
Table 66. Hikma Pharmaceuticals Company Summary
Table 67. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Offerings
Table 68. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Hikma Pharmaceuticals Key News & Latest Developments
Table 70. Sun Pharma Company Summary
Table 71. Sun Pharma Narcotic (Opioid) Drugs Product Offerings
Table 72. Sun Pharma Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Sun Pharma Key News & Latest Developments
Table 74. Endo Pharmaceuticals Company Summary
Table 75. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Offerings
Table 76. Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Endo Pharmaceuticals Key News & Latest Developments
Table 78. Allergan Company Summary
Table 79. Allergan Narcotic (Opioid) Drugs Product Offerings
Table 80. Allergan Narcotic (Opioid) Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Allergan Key News & Latest Developments
List of Figures
Figure 1. Narcotic (Opioid) Drugs Segment by Type in 2022
Figure 2. Narcotic (Opioid) Drugs Segment by Application in 2022
Figure 3. Global Narcotic (Opioid) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Narcotic (Opioid) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Narcotic (Opioid) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2022
Figure 8. By Type - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 16. US Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 28. China Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Narcotic (Opioid) Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Narcotic (Opioid) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Purdue Pharma Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mallinckrodt Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amneal Pharma Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Collegium Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Mylan Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sun Pharma Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Allergan Narcotic (Opioid) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
